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The X-chromosome is often excluded from genome-wide associ-
ation studies because of analytical challenges. Some have been in-
vestigated such as the random, skewed or no X-inactivation model
uncertainty. Others have received little to no attention such as the
value in considering non-additive and gene-sex interaction effects,
and the inferential consequence of choosing different baseline alleles.
Here we propose a unified and flexible regression-based association
test for the X-chromosome. We provide theoretical justifications for
its robustness in the presence of various model uncertainties, as well
as for its improved power under certain alternatives when compared
with the existing approaches. For completeness, we also revisit the
autosomes and show that the proposed framework leads to a robust
and sometimes much more powerful test than the standard method.
Finally, we provide supporting evidence by revisiting several pub-
lished association studies. Supplementary materials for this article
are available online.
1. Introduction. Genome-wide association studies have become ubiq-
uitous, delivering significant insights into the genetic determinants of com-
plex traits in the past decade (Visscher et al., 2017). For this reason, it is
surprising that it is not a common practice to include the X-chromosome
in genome-wide association studies (Wise et al., 2013; Konig et al., 2014).
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The X-chromosome differs from the autosomes in that males have only one
copy of the X-chromosome while females have two; and at any given genomic
location in females one of the two copies may be silenced (Gendrel & Heard,
2011), referred to as X-chromosome inactivation (XCI). The choice of the si-
lenced copy could be random or skewed towards a specific copy (Wang et al.,
2014). These unique aspects lead to more complex analytic considerations
for genetic association studies of X-chromosome variants, such as for single
nucleotide polymorphisms (SNPs).
A SNP has two alleles, r and R, of which one is the the reference allele
and the other is the alternative allele with allele frequency f . An autosome
SNP has three genotypes regardless of sex, namely G = (rr, rR,RR). In an
association analysis of an autosome SNP, the common practice is to simply
model a binary or continuous phenotype Y as an additive function of the
number of copies of the alternative allele present in G, that is G = (0, 1, 2).
Although both dominant G = (0, 1, 1) and recessive G = (0, 0, 1) genetic
models of inheritance are possible, among these one degrees of freedom (1
d.f.) models, the additive model retains reasonable power even if the true
genetic model is dominant or recessive (Hill et al., 2008; Bush & Moore,
2012). Alternative parameterizations include the 2 d.f. genotypic model that
incorporates both the additive GA = (0, 1, 2) term and the over-dominance
term GD = (0, 1, 0). (For the remainder of the paper, we use dominant and
over-dominance interchangeably referring to GD = (0, 1, 0), unless specified
otherwise.) However, the genotypic test is known to be less powerful than the
additive test due to the increased d.f., which is unnecessary if the additivity
assumption holds.
A simple additive coding for an X-chromosome SNP is, however, not
immediate, and several additional points require attention. Table 1 de-
scribes eight analytical considerations and challenges (C1-C8) present in
X-chromosome-inclusive association studies.
Several association methods have been developed for the X-chromosome,
but each solves only some of C1-C8. For example, Zheng et al. (2007) con-
sidered only binary outcomes for which both genotype- and allele-based
association tests are applicable. Allele-based association test is locally most
powerful, but it is sensitive to the Hardy-Weinberg equilibrium (HWE) as-
sumption (Sasieni, 1997; Zheng, 2008). Clayton (2008, 2009) discussed ana-
lytical strategies assuming the X-chromosome is always inactivated. Hickey
& Bahlo (2011) and Loley et al. (2011) performed simulation studies, each
providing a thorough method comparison, e.g. between tests of Zheng et al.
(2007) and Clayton (2008). Konig et al. (2014) provided a detailed guideline
for including the X-chromosome in genome-wide association studies, rec-
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Table 1
Eight analytical considerations and challenges, C1-C8, present in
X-chromosome-inclusive association studies. C1-C3 are relevant for both the
autosomes and X-chromosome, and C4-C8 are more specific to the X-chromosome.
Problem Solution Relevant
Sections
C1: quantitative traits vs. binary outcomes
C2: genotype-based vs. allele-based association methods
Allele-based association tests, comparing allele fre-
quency differences between cases and controls, are lo-
cally most powerful. However, they analyze binary out-
comes only and are sensitive to the Hardy-Weinberg
equilibrium (HWE) assumption (Sasieni, 1997).
Genotype-based regression models, Y -on-
G, support various types of outcome data,
account for covariate effects with ease, and
are robust the HWE assumption.
Sections 1
and 2
C3: 1 d.f. additive vs. 2 d.f. genotypic models (both the additive and over-dominance effects)
Implementing a Y -on-G regression requires assumptions
of the underlying true genetic model, e.g. 1 d.f. additive
or 2 d.f. genotypic model. For the autosomes, the most
common practice is to use the additive test which has
better power than the genotypic test under (approxi-
mate) additivity, but it cannot capture over-dominant
effects. The exact trade-off, however, is not clear.
We provide analytical and empirical
evidences supporting the use of geno-
typic model when analyzing either the
autosomes or X-chromosome. For the
X-chromosome, considering the over-
dominance effect has the added benefit
of resolving of the skewed X-inactivation
uncertainty issue.
Sections 2,
3.3, and
4, and C7
below
C4: sex as a covariate vs. no S main effect
Unlike the autosomes, sex is a confounder when ana-
lyzing the X-chromosome for traits exhibiting sexual di-
morphism (e.g. height and weight). Even for the auto-
somes, sex can be a confounder if allele frequencies differ
significantly between males and females.
To maintain the correct type I error rate
control, sex main effect must be consid-
ered particular when analyzing the X-
chromosome. The resulting association test
is also invariant to the choice of the base-
line allele.
Sections 3.1
and 5, and
C8 below.
C5: gene-sex interaction vs. no G× S interaction effect
Gene-sex interaction might exist, but there is a concern
over loss of power due to increased degrees of freedom.
In addition, what is the interpretation of gene-sex inter-
action effect in the presence of X-inactivation?
Under no interaction, power loss of mod-
elling interaction is, surprisingly capped at
11.4%. Models including the G× S covari-
ate lead to tests invariant to the assump-
tion of X-chromosome inactivation status.
Sections 2.1,
3.2, and 3.4,
and C6 be-
low
C6: X-chromosome inactivation (XCI) vs. no XCI
XCI occurs if one of the two alleles in a genotype of a
female is silenced. Individual-level XCI status requires
additional biological information that are not typically
available to genetic association studies. Assuming XCI
or no XCI at the sample level leads to different genotype
coding strategies (Table 2), and it was thought that this
will always lead to different association results.
XCI uncertainty implies sex-stratified ge-
netic effect which can be analytically repre-
sented by the G×S interaction effect. Teas-
ing apart these different biological phe-
nomenons require other ‘omic’ data and
additional analyses.
Sections 3.2
and 5, and
C5 above
C7: If XCI, random vs. skewed X-inactivation
If the choice of the silenced allele in females is skewed
towards a specific allele, the average effect of the rR
genotype is no longer the average of those of r and R.
XCI skewness is statistically equivalent to
a dominant genetic effect.
Section 3.3
and C3
above
C8: the choice of the baseline allele for association analysis, r vs. R
For the autosomes, switching the two alleles does not
affect the association inference. Is this true for the X-
chromosome?
It is not always true for the X-chromosome,
unless S is included in the model.
Sections 3.1
and 5, and
C4 above
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ommending different tests for different model assumptions (e.g. presence or
absence of an interaction effect, and the XCI status), but it is difficult to
check these assumptions in practice. Gao et al. (2015) developed a toolset for
conducting X-chromosome association studies, implementing some of the ex-
isting methods. More recently, Chen et al. (2017) improved the sex-stratified
tests by eliminating genetic model assumptions, but their method is limited
to analyzing binary traits and genetic main effects. Focusing on XCI, Wang
et al. (2014) proposed a frequentist maximum likelihood solution to deal with
no, random or skewed X-inactivation, and in their follow-up work Wang et al.
(2017) provided a model selection method. In contrast, Chen et al. (2018)
applied the Bayesian model averaging principle (Draper, 1995) to the XCI
uncertainty problem. However, both approaches assumed additivity, and it
is not clear how to include non-additive genetic effects, along with unknown
XCI status, in their respective analytical formulation. The value in consid-
ering over-dominance and gene-sex interaction effects, and the inferential
consequence of parameterizing the model in terms of defining different base-
line (reference or alternative) allele when analyzing the X-chromosome, have
received little to no attention.
Table 2 summarizes the various covariate coding schemes for analyzing an
X-chromosome SNP when considering all the analytical challenges outlined
in Table 1. Note that when the choice of the baseline allele is varied (i.e.
either r or R) and the XCI status is unknown, there are four ways to code
the additive covariate GA, and two ways to code the gene-sex interaction
covariate GS.
Using the notations in Table 2, it is immediately clear why the choice of
the baseline allele can matter for association analyses of the X-chromosome.
Under no XCI, if r was assumed to be the baseline allele there would be
one copy of allele R in genotype rR or R, so rR and R would be grouped
together for association analyses. However, if R was chosen to be the baseline
allele, genotypes rR and r would be grouped together, resulting in different
inference; this is in stark contrast to what is known for the autosomes for
which the choice of the baseline allele does not affect association evidence.
The goal of this paper is to propose a theoretically justified and robust X-
chromosome association method that can simultaneously deal with all eight
analytical challenges outlined in Table 1. The proposed method is regression-
and genotype-based, allowing for either a continuous or binary phenotype as
the outcome variable, adjusting for covariate effects and robust to departure
from HWE. The recommended test has three degrees of freedom, including
both additive and dominant genetic effects, as well as a gene-sex interac-
tion effect. We show analytically that this ensures that the various model
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Table 2
Covariate coding schemes for examining the additive, dominant, gene-sex
interaction, and sex effects under different X-chromosome inactivation and
baseline allele assumptions. The subscripts A and D represent additive and
dominant effects, R or r represents the designated allele of which we count the number of
copies present in a genotype (also known as the ‘risk’ allele, and the corresponding
baseline allele would be r or R, respectively), and I or N denotes X-chromosome
inactivated or not inactivated.
X-chromosome Coding Schemes
Effect Covariate Allele Inactivation (Females) (Males)
Interpretation Notation Choice (XCI) Status rr rR RR r R
GA,R,I R Yes 0 0.5 1 0 1
Additive GA,r,I r Yes 1 0.5 0 1 0
GA GA,R,N R No 0 1 2 0 1
GA,r,N r No 2 1 0 1 0
Dominant GD GD Either Either 0 1 0 0 0
Gene-Sex Interaction GSR R Either 0 0 0 0 1
GS = GA × S GSr r Either 0 0 0 1 0
Sex S S Either Either 0 0 0 1 1
uncertainties − no, random, or skewed X-chromosome inactivation, and the
choice of the baseline allele − are accounted for. Desirably, the power of the
proposed test is well maintained across different genetic models, despite its
increased degrees of freedom as compared to a simple additive test.
We organize the remainder of the paper as follows. To inform the choice
for X-chromosome association studies, in Section 2 we first shed new light
on the merits of genotypic models in the familiar context of analyzing auto-
some SNPs, and provide analytical power results across all possible genetic
models. In Section 3, we present our main theory to address the challenges
specific to the X-chromosome, as well as empirical results from simulation
studies. In Section 4, we provide corroborating evidence from several appli-
cations in favour of the proposed method. Finally in Section 5, we discuss
the limitations of our approach and possible future work.
2. Additive vs. Genotypic Models (C3): Robustness of the Geno-
typic Test. For completeness and a more clear demonstration of this
particular model selection challenge in the X-chromosome, we first revisit
phenotype-genotype association studies of the autosomes where, tradition-
ally, only the additive coding is implemented. We define the additive model
and genotypic model using the generalized linear regression framework (Mc-
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Cullagh & Nelder, 1989). Let g be the link function, the additive model
is
(2.1) g(E(Y )) = β0 + βAGA,
and the genotypic model is
(2.2) g(E(Y )) = β0 + βAGA + βDGD,
where without loss of generality for an autosome SNP, r is the reference al-
lele and chosen to be the baseline, R is the alternative allele and designated
as the ‘risk’ allele with population allele frequency f , and GA = (0, 1, 2)
and GD = (0, 1, 0) for the three genotypes, rr, rR and RR, irrespective of
sex. Additional covariates such as environmental factors Es can be readily
added to both models, and the sex S covariate in this case can be statis-
tically viewed as part of the Es since we are analyzing autosome SNPs.
The three genotype groups have population frequencies (1− f)2, 2f(1− f),
and f2 assuming Hardy-Weinberg equilibrium. However, we note that the
HWE assumption is not required for validity of the proposed regression- and
genotype-based association test.
2.1. Power comparison using the general theory of chi-squared distribu-
tions. Let W1 be the standard association test statistic for testing H0 :
βA = 0 based on the additive model (2.1), and assume that W1 follows an
asymptotic chi-squared distribution, χ2(1,ncp1). The non-centrality parame-
ter, ncp1, captures the true genetic effect size, allele frequency, variance of
the error term, and sample size which we study in the next section. Here we
simply specify ncp1 = 0 under the null of no association and > 0 under an
alternative model. Similarly, let W2 and χ
2
(2,ncp2)
be the corresponding test
statistic and its asymptotic distribution for testing H0 : βA = 0 and βD = 0
jointly using the genotypic model (2.2).
The power difference between W1 and W2 depends on both the non-
centrality parameters and the nominal type I error rate, α. When ncp1 =
ncp2 = 0 or α = 0, both W1 and W2 have no power. At the other extreme
when both ncp1 and ncp2 are sufficiently large or α close to 1, both W1 and
W2 have power close to 1. Thus, we expect meaningful power comparison
when both the non-centrality parameter and α have moderate values.
First, let us assume that the true genotype effect is indeed additive to
study the maximum power loss induced by unnecessarily including the domi-
nant term GD. In that case, ncp2 = ncp1 = ncp and W2 is less powerful than
W1. Varying ncp and α values and under additivity, we numerically com-
pute the power of W1 and W2 as functions of ncp and α for ncp ∈ [0, 100]
A ROBUST AND POWERFUL APPROACH TO X-INCLUSIVE GWAS 7
and − log10 α ∈ [0, 15]. The maximum power loss of a 2 d.f. genotypic test
is, surprisingly, capped at 11.4%, regardless of the true genetic effect size,
sample size, and significance level; the maximum occurs at α = 0.0025 and
ncp = 10.6. (At the genome-wide significance level of α = 5 × 10−8 (Dud-
gridge & Gusnanto, 2008), the maximum power loss is 10.3% occurring when
ncp = 31.4.) Figure S1 in the Supplementary Materials provides heat plots
for power as functions of ncp and α for the two tests, as well as for power
loss comparing W2 with W1 under additivity.
It needs to be noted that the maximum 11.4% holds for comparing any
2 d.f. χ2 test with a 1 d.f. χ2 test, because the derivation is based on ncp
and α alone. For instance, for the phenotype-genotype association analyses
of interest here, if an assumed 1 d.f. recessive genetic model was the correct
one, then power loss of using the 2 d.f. genotypic model is also capped at
11.4%, regardless of the true genetic effect size, sample size, and significance
level.
With a bounded power loss, we next investigate the potential power gain
(or loss) by using W2 when the true genotype effect is not additive. In the
presence of a dominant effect, ncp2 = ncp1 + ∆12, where ∆12 > 0 and the
value depends on sample size and the degree of departure from additivity.
Compared to the maximum power loss of using the genotypic test under
additivity, the maximum power gain under non-additivity can be technically
as large as 1 − α (i.e. close to 100%), when ncp1 → 0 and ∆12 → ∞.
However, to provide more specific numerical results, we consider ncp1 = 5,
10 or 15, ∆12 ranging from 0 to 10, and α = 0.0025, the worse-case scenario
derived above. Results show that once ∆12 is as large as half of ncp1 (i.e.
ncp2 ≈ 1.5 · ncp1), the power gain is bigger than power loss when ∆12 = 0
(Figure S2). Together these two observations suggest that genotypic models
should be considered for use in association studies of autosome SNPs.
2.2. Power comparison using specific genetic models for the autosomes.
We rewrite the GLMs (2.1) and (2.2) in matrix forms, g(E(Y )) = Xβ,
where β = (β0, βA)
′ for the additive model and β = (β0, βA, βD)′ for the
genotypic model, and X is the corresponding design matrix. In each case,
β = (β1, β2)
′ and we want to test H0 : β2 = 0, where β2 contains the
parameter(s) of interest, e.g. β2 = (βA, βD) for the genotypic model (2.2).
To distinguish between the combined regression coefficients in vector form
and its partition, we use bold symbols (β) to denote the combination of two
partitions, and non-bold symbols (β) to denote each partition throughout
our work, although each partition may have dimension ≥ 1. To compute the
non-centrality parameter, we first partition the expected Fisher information
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matrix accordingly,
H(β1, β2) =
[
H11(β1, β2) H12(β1, β2)
H21(β1, β2) H22(β1, β2)
]
.
We can then obtain the non-centrality parameter, where
ncp = β′2[H22(β1, 0)−H21(β1, 0)H−111 (β1, 0)H12(β1, 0)]β2.
The technical details for computing this ncp for different genetic models are
given in Appendix B.
Note that when the true model is genotypic but the additive model was
used, the computation of the non-centrality parameter is less straightforward
because of the model misspecification. Although the derivation is difficult
under the standard genotype coding as defined above, a re-parametrization
can considerably simplify the computation (Begg & Lagakos, 1992); see Ap-
pendix C for technical details.
Figure 1 shows power of the two tests (the 1 d.f. additive test and 2
d.f. genotypic test) for association analyses of an autosome SNP across a
range of dominant effects including no dominant effect, and when n = 1, 000
and α = 0.0025; power were computed based on analytically derived ncps
and further confirmed by simulation studies, and see Figure S3 for the non-
centrality parameter values corresponding to Figure 1. We fix the additive
effect at βA = 0.3 while varying the dominant effect βD from −0.6 to 0.6,
and we consider three allele frequencies, f = 0.2, 0.5 and 0.8. The results
show that the power gain of using the genotypic test (the red solid curve) as
compared with the additive test (the black dashed curve) can be more than
40%; the increase can be bigger for other settings (results not shown). In
contrast, we have shown in Section 2.1 that the maximum power loss of using
the genotypic test under additivity is never more than 11.4% analytically.
Indeed, when f = 0.5 and βD = 0, ncp1 = ncp2 = ncp ≈ 10.6; recall
that ncp = 10.6 and α = 0.0025 result in maximum power loss of the
genotypic test under additivity (Figure S1). That is, the maximum power
loss shown in Figure 1 is close to the global maximum possible, while the
power gain seen here can be made bigger by considering other scenarios.
Thus, without sacrificing much power under the worse case scenario (11.4%
when α = 0.0025 and ncp = 10.6), the potential power gain of the robust
genotypic test can be significant across different genetic models.
Remark 1: For robust and powerful association analysis of autosome SNPs,
we recommend the following model,
g(E(Y )) = β0 + βAGA + βDGD,
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Fig 1. Power comparison between the additive and genotypic tests for associ-
ation analyses of autosome SNPs across a range of dominant effects, including
no dominant effect. The additive effect is fixed at βA = 0.3, while the dominant ef-
fect βD ranges from −0.6 to 0.6. The allele frequency f = 0.2, 0.5 and 0.8 for the three
plots, respectively, from left to right, the sample size n = 1, 000, and the size of the test
α = 0.0025. The black dashed curves are power of testing βA = 0 using the additive model
(2.1), and the red solid curves are power of testing βA = βD = 0 using the genotypic model
(2.2). Result explanations are provided in Sections 2.2 and 5.
and the corresponding 2 d.f. genotypic test, testing
H0 : βA = βD = 0.
Note that, in practice, the regression model should include relevant covariate
Es which are omitted here for notation simplicity. These results also suggest
that investigation of the dominant effect for the X-chromosome may be
warranted, which we investigate below.
3. X-chromosome Specific Considerations (C4-C8).
3.1. Sex as a confounder (type I error control) and the choice of the base-
line allele (C4 and C8): always modelling the S main effect. Sex is a con-
founder for phenotype-genotype association analysis of an X-chromosome
SNP for traits displaying sexual dimorphism. When sex, but not the SNP, is
associated with a trait of interest, omitting sex in the analysis leads to false
positives. This is because sex is inherently associated with the genotypes
of an X-chromosome SNP (Table 2); see Ozbek et al. (2018) for empiri-
cal evidence from simulation studies. Thus, correct control of type I error
rate provides the first argument for always including S as a covariate in
X-chromosome association analyses.
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The second advantage of including the S main effect is more subtle but
consequential nevertheless. As shown in Table 2, the coding of GA depends
on the choice of the baseline allele (i.e. R or r) and the X-inactivation sta-
tus (I for XCI and N for no XCI), resulting in a total of four different
ways of coding the five genotype groups for association analyses, namely
GA,R,I = (0, 0.5, 1, 0, 1)
′, GA,r,I = (1, 0.5, 0, 1, 0)′, GA,R,N = (0, 1, 2, 0, 1)′,
and GA,r,N = (2, 1, 0, 1, 0)
′. Further, GA,R,N and GA,r,N yield different test
statistics, because the two coding schemes lead to different groupings of the
genotypes. Note that under no XCI there is no linear transformation that
makes GA,R,N and GA,r,N equivalent; under XCI GA,R,I = 1 − GA,r,I . An
inference that is invariant to the coding choices may seem difficult, but we
show that this is achievable for models that include sex as a covariate.
Theorem 1. Let M1 and M2 be two generalized linear models with the
same link function g, g(E(Y )) = X1β1 and g(E(Y )) = X2β2, where Y is
the response vector of length n, X1 and X2 are two n × p design matri-
ces, and β1 and β2 are the corresponding parameter vectors of length p. Let
X1 = (X11, X12), where X11 and X12 are n× (p− q) and n× q matrices cor-
responding to, respectively, the (p− q) secondary covariates not being tested
and the q primary covariates of interest, and similarly for X2 = (X21, X22),
and partitioning the regression coefficients accordingly as β1 = (β
′
11, β
′
12)
′
and β2 = (β
′
21, β
′
22)
′. If there exists an invertible p× p matrix
T =
(
T1 T12
0 T2
)
, such that X2 = X1 T and X21 = X11 T1
where T1 and T2 are, respectively, invertible (p − q) × (p − q) and q × q
matrices, then any of the Wald, Score or LRT tests for testing
H0 : β12 = 0 and H0 : β22 = 0
are identical under the two models M1 and M2, resulting in the same as-
sociation inference for evaluating the q primary covariates of interest.
We provide the proof of Theorem 1 in Appendix A. Here, we empha-
size that the primary q covariates being tested are not required to be lin-
ear transformation of each other, e.g., between GA,R,N = (0, 1, 2, 0, 1)
′ and
GA,r,N = (2, 1, 0, 1, 0)
′. Instead, the two sub-design matrices, X11 and X21
corresponding to the secondary p− q covariates (including the unit vector if
modelling the intercept) that are not being tested must be invertible linear
transformations of each other, X21 = X11 T1 in addition to X2 = X1 T .
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This result may seem somewhat surprising, but the two conditions imply
that (a) the two design matrices are equivalent, and (b) under the respective
null hypothesis, the two design matrices are also equivalent resulting in
identical F-test statistics; see Appendix A for technical details.
In our setting when sex is included in the model, consider only the additive
effect for the moment, g(E(Y )) = β0 + βSS + βAGA. Then the two design
matrices corresponding to r or R being the baseline allele, under no XCI,
have the structures of
X1 =

1 0 0
1 0 1
1 0 2
1 1 0
1 1 1
 , X2 =

1 0 2
1 0 1
1 0 0
1 1 1
1 1 0
 .
It is then easy to identify that T1 =
(
1 0
0 1
)
, T12 = (2,−1)′ and T2 = −1
satisfy the two conditions. Thus, even though GA,R,N = (0, 1, 2, 0, 1)
′ and
GA,r,N = (2, 1, 0, 1, 0)
′ are not linear transformation of each other, Theorem
1 allows us to conclude that a (Wald, Score or LRT) test of H0 : βA = 0
based on g(E(Y )) = β0 + βSS + βAGA is invariant to the two GA coding
schemes, GA,R,N and GA,r,N .
Note that the standard case of q primary covariates, X12 and X22 from two
different models, being linear transformation of each other is a special case of
Theorem 1, where all elements in T12 are zero; the first row can be a constant
to allow for a location shift. For example, under the XCI assumption, X12 =
GA,R,I = (0, 0.5, 1, 0, 1)
′ and X22 = GA,r,I = (1, 0.5, 0, 1, 0)′, and X22 =
1−X12. Thus, T1 =
(
1 0
0 1
)
, T12 = (1, 0)
′, and T2 = −1.
At this point in the methodology development, we now have the model
g(E(Y )) = β0 +βSS+βAGA that controls type I error rate and is invariant
to the choice of the baseline allele when there is no XCI. However, in general
the XCI status is unknown. Consider GA,R,I = (0, 0.5, 1, 0, 1)
′ and GA,r,N =
(2, 1, 0, 1, 0)′, and
X1 =

1 0 0
1 0 0.5
1 0 1
1 1 0
1 1 1
 and X2 =

1 0 2
1 0 1
1 0 0
1 1 1
1 1 0
 .
In this case, it is not difficult to show T satisfying the conditions in Theorem
1 does not exit, and the XCI uncertainty remains a challenge.
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3.2. Gene-sex interaction and X-chromosome inactivation (XCI) (C5 and
C6): value in including the GS interaction effect. Throughout the paper,
we define the GS interaction term as GA × S. Depending on the choice
of the baseline allele, GS has two different codings, namely GSR and GSr
as defined in Table 2. In the previous section, we have shown that when
S is included in the model, g(E(Y )) = β0 + βSS + βAGA, the choice of
the baseline allele is no longer a concern if we test H0 : βA = 0 within a
particular XCI assumption. Interestingly, when both S and GS are included
in the model, g(E(Y )) = β0 +βSS+βAGA +βGSGS, by applying Theorem
1 again, testing H0 : βA = βGS = 0 is statistically equivalent between the
different choices of the baseline allele and the assumptions of the XCI status.
For example, consider
X1 =

1 0 0 0
1 0 0.5 0
1 0 1 0
1 1 0 0
1 1 1 1
 and X2 =

1 0 2 0
1 0 1 0
1 0 0 0
1 1 1 1
1 1 0 0
 ,
respectively, for a model assuming XCI and choosing r as the baseline allele
(i.e. tracking the number of the ‘risk” allele R), and for a model assuming
no XCI and choosing R as the baseline allele, we can show that
T1 =
(
1 0
0 1
)
, T12 =
(
2 0
−1 1
)
, and T2 =
(
−2 0
1 −1
)
,
satisfy the linear transformation requirements of Theorem 1.
Figure S4 in the Supplementary Materials summarizes the equivalency be-
tween design matrices that correspond to the different coding schemes stud-
ied so far; all theoretically results have been confirmed empirically via simu-
lations. Figure S4 implies that for association analyses of the X-chromosome,
testing H0 : βA = βGS = 0, based on the g(E(Y )) = β0 + βSS + βAGA +
βGSGS model, is invariant to the choice of the baseline allele and the as-
sumption of the X-inactivation status.
In terms of potential loss of power due to increased degrees of freedom as
compared to testing only the main additive effect, we appeal to the results
from Section 2. Specifically, in the absence of any interaction effect, the
maximum power loss of jointly testing the additive and interaction effects is
capped at 11.4%, while in the presence of an interaction effect, the maximum
power gain can be as high as 1− α.
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3.3. Random vs. skewed X-inactivation (C7): additional value in mod-
elling the dominant GD effect. Similar to analyzing the autosomes, the first
reason for including the dominant effect is to capture potential departure
from additivity, without scarifying significant power in the absence of any
dominant effect. For the X-chromosome, another important reason is that
the dominant effect can also capture skewness of X-inactivation, if present.
Intuitively, if we assume the effects of rr and RR to be, respectively, 0 and
1, the effect of rR will be either 0 or 1 at the individual level, depending on
the inactivated allele. If the two alleles are equally likely to be inactivated
(i.e. random XCI), the average effect of rR is 1/2 at the population level. If
r is more likely to be inactivated (i.e. skewed XCI), the average effect of rR
is greater than 1/2. However, it is not difficult to see that this XCI skewness
is analytically equivalent to a dominant effect which means that the effect of
rR deviates from 1/2. Thus, including the GD covariate not only captures
any dominant effect but also represents any skewness of XCI. The downside
of this analytical equivalency however is that, without additional biological
information, one can not distinguish between the two scenarios.
Note that coding of the dominant covariate GD (Table 2) is invariant
to the choice of the baseline allele or XCI status. Thus, including GD in
the model does not change the model relationships as specified in Figure
S4. Table 3 summarizes the behaviours of various regression models. Jointly
testing H0 : βA = βD = βGS = 0, based on the g(E(Y )) = β0 + βSS +
βAGA + βDGD + βGSGS model M4, ensures that the inference is invariant
to the assumptions of the XCI status and baseline allele, and accounts for
over-dominance and XCI-skewness if present, providing strong support for
its use.
3.4. Power study of the X-chromosome.
3.4.1. Using the general theory of chi-squared distributions. One concern
with the use of the proposed 3 d.f. test is the potential loss of power due
to the increased degrees of freedom. However, we can obtain results similar
to those shown in Section 2.1. Specifically, let W1 be a 1 d.f. test statistic
that is χ2(1,ncp1) distributed, and W3 be the proposed 3 d.f. test statistic
that is χ2(3,ncp3) distributed. When there are no dominant or interaction
effects and the XCI status is precisely known, W1, derived from g(E(Y )) =
β0 + βSS + βAGA, with the correct genotype coding, is the optimal test
and ncp1 = ncp3 = ncp. In that case, the maximum power loss of W3,
remarkably, is capped at 18.8%, regardless of the true additive effect size,
sample size and test size; the maximum occurs at α = 0.0008 and ncp = 13.4
(Figure S1 in Appendix D). (At α = 5×10−8 (Dudgridge & Gusnanto, 2008),
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Table 3
Properties of different regression models in the presence of
X-chromosome-specific analytical challenges, C4-C8, as detailed in Table 1.
C4: Sex as a confounder and type I error control; C5: Gene-sex interaction; C6: X
chromosome inactivation (XCI) vs. no XCI; C7: Random vs. skewed XCI; C8: Choice of
the baseline allele. × indicates a problem if using the corresponding model and test, and√
means no problem. Note that whole-genome considerations such as C1 (continuous vs.
binary traits) and C2 (Hardy-Weinberg equilibrium vs. disequilibrium) are naturally dealt
with by the genotype-based regression approach, and C3 (the dominant effect) is addressed
here. Relevant covariate Es should be included in the model but omitted here for notation
simplicity. Joint testing of H0 : βA = βD = βGS = 0 based on M4 is the recommended,
most robust approach; see Figures 2 and S1 for power comparisons among M1 −M4.
Model, g(E(Y )) = Testing H0 : C4/C8 C6/C7 C5
M0 : β0 + βAGA βA = 0 × × ×
M1 : β0 + βSS + βAGA βA = 0
√ × ×
M2 : β0 + βSS + βAGA + βDGD βA = βD = 0
√ × √
M3 : β0 + βSS + βAGA + βGSGS βA = βGS = 0
√ √ ×
M4 : β0 + βSS + βAGA + βDGD + βGSGS βA = βD = βGS = 0
√ √ √
the maximum power loss is 17.7% occurring at ncp = 32.6.) In the presence
of either a dominant or interaction effect or both, however, the power gain
of the proposed 3 d.f. test can be in theory as high as 1− α.
Compared with a 2 d.f. test when model g(E(Y )) = β0 + βSS + βAGA +
βDGD or g(E(Y )) = β0 + βSS + βAGA + βGSGGS being correctly specified,
the global maximum power loss of the proposed 3 d.f. test is capped at 7.7%,
occurring at α = 9.12× 10−5 and ncp = 19; at α = 5× 10−8 (Dudgridge &
Gusnanto, 2008), the maximum power loss is 7.5% occurring at ncp = 34.2.
See Figure S1 for heat plots of power comparisons.
3.4.2. Using different genetic models for the X-chromosome. We next
provide some empirical results based on specific genetic models. Note that
tests derived from models that do not include sex as a covariate are suscep-
tible to type I error rate inflation. Thus, power comparisons here focus on
M1 −M4 as specified in Table 3.
Similar to studies of the autosomes in Section 2.2, we need to compute
the asymptotic non-centrality parameters of each test statistic for differ-
ent genetic models with varying degrees of additive, dominant and inter-
action effects, and under different assumptions of the baseline allele and
X-inactivation status. We provide the technical details in Appendices B and
C.
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We consider n = 1, 000, α = 0.0008 as derived above in Section 3.4.1,
and allele frequency fmale = ffemale = 0.2 or 0.5. Results for other param-
eter values, including differential f values between males and females, are
provided in the Supplementary Materials; the case when the baseline alle-
les differ between males and females is discussed in Section 5. Because of
the various analytical equivalencies (between GS interaction and XCI sta-
tus, and between dominant effect and skewed XCI), we specify the averaged
effect size for each of the five genotype groups, i.e., µrr, µrR, µRR, µr, and
µR. We fix µrr = −0.3, µRR = 0.3 and µr = 0, and vary µrR and µR from
−0.6 to 0.6. Note that fixing µrr and µRR is equivalent to fixing the ad-
ditive effect βA = 0.6 under XCI or βA = 0.3 under no XCI, and varying
µrR is equivalent to varying the dominant effect βD from −0.6 to 0.6. The
link with the interaction effect βGS is less clear. Under the XCI assumption,
βGS = (µR − µr) − (µRR − µrr)/2 = µR − 0.3, while under the no XCI
assumption, βGS = (µR − µr)− (µRR − µrr)/4 = µR − 0.15. So, for the µR
values considered here, βGS ranges from −0.9 to 0.3 under XCI, and from
−0.75 to 0.45 under no XCI. For ease of interpretation, Figure 2 uses the
‘interaction’ and ‘dominant’ terms to denote the varying degrees of µrR and
µR.
Results in Figure 2 demonstrate the merits of the proposed method (test-
ing βA = βD = βGS = 0 jointly, the red solid curves). While there could be
some power loss in the worse case scenario (no GD dominant or GS interac-
tion effects), it is theoretically capped at 18.8% regardless of the parameter
values. On the other hand, compared with the standard 1 d.f. additive test
(testing βA = 0, the black dashed curves), power gain can be 70% for the
cases considered here. When the allele frequency is 0.2 (Figure 2A), the per-
formance of the 2 d.f. additive and interaction test (testing βA = βGS = 0,
the orange dotted curves) is close to the proposed 3 d.f. test. However, that
is no longer the case when f = 0.5 (Figure 2B), where the 2 d.f. additive
and dominant test (testing βA = βD = 0, the green dot-dashed curves) is
better and close to the proposed 3 d.f. test. Figures S5 provides additional
results for other parameter values, all showing the robustness of the proposed
method.
Remark 2: For robust and powerful association studies of the X-chromosome,
we recommend the following model,
g(E(Y )) = β0 + βSS + βAGA + βDGD + βGSGS,
and the corresponding 3 d.f. test, jointly testing
H0 : βA = βD = βGS = 0,
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A. ffemale = fmale = 0.2
B. ffemale = fmale = 0.5
Fig 2. Power comparison for analyzing X-chromosome SNPs. Black dash lines
for testing βA = 0 based on model M1 as specified in Table 3, green dot-dash curves for
testing βA = βD = 0 based on model M2, orange dotted curves for testing βA = βGS = 0
based on model M3, and red solid curves for testing βA = βD = βGS = 0 based on the
proposed model M4. Upper panels in A and B examine power as a function of the
dominant effect (or skewness of XCI). Lower panels in A and B examine power as a
function of the gene-sex interaction effect (or XCI status). Results for other parameter
values including differential f between males and females are shown in Figures S5. The
analyses here assume that the true baseline allele is known and f being the allele frequency
of the true ‘risk’ allele, and the true XCI status is known at the population level. Unlike
the other methods (M1-M3), the proposed method (M4) is invariant to the assumptions of
the baseline allele and XCI status. Result explanations are provided in Sections 3.4.2.
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which not only resolves the C1−C8 analytical challenges simultaneously,
but also has the best overall performance across different underlying genetic
models. Note that the complete regression model includes relevant covariate
Es that are omitted here for notation simplicity.
4. Applications to Published Association Studies.
4.1. Re-analyses of the 60 autosome SNPs potentially associated with var-
ious complex traits, selected by Wittke-Thompson et al. (2005). We first re-
analyze the 60 autosome SNPs selected by Wittke-Thompson et al. (2005)
from 41 case-control association studies of various complex traits, including
Alzheimer disease and breast cancer; the genotype count data are available
from Table 1 of Wittke-Thompson et al. (2005). Although these SNPs were
originally selected by Wittke-Thompson et al. (2005) for a study of depar-
ture from Hardy-Weinberg equilibrium, genotype-based methods are robust
to the HWE assumption (Sasieni, 1997).
Here we focus on comparing the standard 1 d.f. additive test with the pro-
posed 2 d.f. genotypic test that jointly tests both the additive and dominant
effects for the autosomes. We observe that, for about two thirds of the SNPs,
p-values of the genotypic test are smaller than those of the additive test, and
sometimes substantially so (Figure S6 in the Supplementary Materials). For
the remaining SNPs, the genotypic p-values are only slightly bigger than the
additive p-values. Although these 60 autosome SNPs can only be presumed
to be associated with the various complex traits, the empirical evidence here
is consistent with the analytical results in Section 2.
4.2. Evidence from the first (autosome only) genome-wide association
study of WTCCC (2007). Further, similar patterns are observed in the
first (autosome only) genome-wide association study performed by the Well-
come Trust Case Control Consortium (2007). Their Table 3 lists regions of
the genome showing the strongest association signals and provides results
from both the 1 d.f. trend test (statistically similar to the additive test con-
sidered here) and the 2 d.f. genotypic tests. Their results show that if the
additive test provides a smaller p-value, the p-value of the genotypic test is
at most one order of magnitude larger, e.g. 1.16 × 10−13 vs. 1.79 × 10−14
for rs1333049 associated with coronary artery disease, the second SNP in
Table 3 of WTCCC (2007). On the other hand, the p-value of the 2 d.f.
genotypic test can be several orders of magnitude smaller for other SNPs,
e.g. 6.29×10−8 vs. 2.19×10−4 for rs420259 associated with bipolar disorder,
the first SNP in Table 3 of WTCCC (2007). Similar statement can be made
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for the Bayes factors obtained under the 1 d.f. additive and 2 d.f. genotypic
models by the WTCCC (2007).
4.3. Re-analyses of the (X-chromosome-inclusive) genome-wide associa-
tion study of Sun et al. (2012) . The data consists of 3,199 unrelated in-
dividuals with cystic fibrosis (CF) and 570,724 genome-wide SNPs, after
standard quality control (Sun et al., 2012). In total, there are 574 cases with
meconium ileus (intestinal obstruction at birth seen in ≈ 15% of CF pa-
tients (Dupuis et al., 2016)) and 2,625 CF controls, 1,722 males and 1,477
females, and 556,445 SNPs from the autosomes and 14,279 SNPs for the X-
chromosome. In Sun et al. (2012) a genome-wide association study of meco-
nium ileus using the standard 1 d.f. additive test for the autosome SNPs was
conducted, and X-chromosome inactivation for the X-chromosome SNPs was
assumed (i.e. model M1 in Table 3 with genotype coding under the assump-
tion of XCI). Here we re-analyze the autosomes and X-chromosome SNPs
to demonstrate the utility of the proposed methods.
For the autosomes, we contrast the standard 1 d.f. additive test with the
proposed 2 d.f. genotypic test as discussed in Section 2. Figure 3A shows
the results for the top 15 ranked autosome SNPs, ordered by the minimal p-
value of additive and genotypic tests; the lines connecting the SNPs are used
only for visualization purposes. The results here are consistent with those in
Section 4.1 and 4.2: If the p-values of the standard 1 d.f. additive test (the
black dashed curve) are smaller, then those from the recommended 2 d.f.
genotypic test (the red solid curve) are close in magnitude, while the reverse
is not true. For example, p-value of the recommended 2 d.f. genotypic test
for the 6th SNP (rs2657147) in the plot is more than four orders of magni-
tude smaller than that of the 1 d.f. additive test. In this case, the genotype
counts for rr, rR, and RR are (210, 312, 52) for cases and (1012, 1192, 421)
for controls, which yields case/control ratios of (0.208, 0.262, 0.124) clearly
suggesting an over-dominance pattern. The HWE test in the control sam-
ple has p-value p = 0.026, though smaller than 0.05 clearly passing the
standard quality control for genotyping errors requiring HWE test p-value
less than 10−8. However, whether this is a true new finding requires further
investigation. Figures S7 and S8 in the Supplementary Materials provides
genome-wide results.
For the X-chromosome, we compare the M1 −M4 models and their cor-
responding tests as detailed in Table 3 and Section 3. For each SNP, we
perform six different association tests, depending on which of the M1 −M4
models was used and if the XCI status needed to be specified, because (a)
sex must be included to ensure correct type I error rate control and models
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A. Autosome Results
B. X-chromosome Results
Fig 3. Results of a genome-wide association study of meconium ileus in cystic
fibrosis subjects. In total, 3,199 independent cystic fibrosis subjects, 556,445 SNPs au-
tosome SNPs and 14,279 X-chromosome SNPs are analyzed. The SNPs are ordered by the
minimal p-value of the different tests considered, and the lines connecting the SNPs are
used only for visualization purposes. A: These top 15 ranked autosome SNPs are selected
based on either the 1 d.f. additive test or the 2 d.f. genotypic test. The black dashed curve
for testing βA = 0 using the standard additive model, and the red solid curve for testing
βA = βD = 0 using the recommend genotypic model that is most robust for analyzing
the autosomes. B: These top 15 ranked X-chromosome SNPs are selected based on any
of the six tests based on M1 −M4 models in Table 3: the Black dashed curve for testing
βA = 0 based on M1 assuming X-chromosome inactivation (XCI), the brown long-dashed
curve for testing βA = 0 based on M1 assuming no XCI , the green dot-dashed curve for
testing βA = βD = 0 based on M2 assuming XCI, the blue two-dashed curve for test-
ing βA = βD = 0 based on M2 assuming no XCI, the orange dotted curve for testing
βA = βGS = 0 based on M3 (invariant to the XCI assumptions if GS is included in the
model and tested), and the red solid curve for testing βA = βD = βGS = 0 based on the
recommended model M4 that is most robust for analyzing the X-chromosome.
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including S are invariant to the choice of the baseline allele (Section 3.1),
and (b) models including the gene-sex interaction effect are invariant to the
assumption of X-inactivation status (Section 3.2). Figure 3B shows the re-
sults for the top 15 ranked X-chromosome SNPs, ordered by the minimal
p-value of all six tests. The empirical results here are clearly consistent with
our earlier analytical results in Section 3.4, showing that joint modelling and
testing the additive, dominant and gene-sex interaction effects is the most
robust association approach for analyzing the X-chromosome.
5. Discussion. We have shown that in association studies of the X-
chromosome, sex main effect must be included to achieve correct type I error
rate control. The inclusion of sex also addresses the complication of baseline
allele specification that otherwise affects association inference for the X-
chromosome. Although the method developed here is motivated by genetic
association studies of the X-chromosome, Theorem 1 is applicable to other
settings where model uncertainty plays a role. For association studies of the
autosomes, sex is not routinely included. However, sex can be a confounder
for the autosomes as well, e.g. when there are differential female and male
allele frequencies. Thus, we recommend to always include sex as a covariate
in association analyses of either autosome or X-chromosome SNPs.
The specific coding for sex does not have an impact on our proposed
approach. In Table 2, a female is coded as 0 and a males as 1, and the
interaction GD×S is reduced to be 0. If a female was coded as 1 and a male
as 0, then GD × S is the same as GD. Thus, in either case it is redundant
to include GD × S in our purposed model.
For genotyping coding, we have used the statistical term baseline allele,
which can be either the reference allele or the alternative allele; the other
allele can be called the ‘risk’ allele. In practice, some investigators might
choose to define the major allele (the allele with population allele frequency
> 0.5) as the baseline allele and the minor allele as the ‘risk’ allele. Al-
though these different preferences do not affect inference based on models
that include sex main effect (Section 3.1), the allele frequency difference
between females and males in theory can be so substantial that the minor
alleles differ between the two sex groups. The inferential consequence of this
technical complication, to the best our knowledge, has not been studied be-
fore. However, we note that as we model the gene-sex interaction effect in
association analyses of either the autosome or X-chromosome SNPs, we es-
sentially allow for different baseline alleles between females and males. We
can prove this theoretically by applying Theorem 1. For example, consider
an autosome SNP for which we either define the same or different baseline
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alleles for males and females. If we introduce the GS interaction covariate
and consider g(E(Y )) = β0 + βSS + βAGA + βGSGS, we have the following
two design matrices,
X1 =

1 0 0 0
1 0 1 0
1 0 2 0
1 1 0 0
1 1 1 1
1 1 2 2

and X2 =

1 0 0 0
1 0 1 0
1 0 2 0
1 1 2 2
1 1 1 1
1 1 0 0

.
It is easy to show that
T1 =
(
1 0
0 1
)
, T12 =
(
0 0
2 2
)
, and T2 =
(
1 0
−2 −1
)
satisfy the conditions of Theorem 1. As a result, testing H0 : βA = βGS = 0
are equivalent between the two models. Similar results can be obtained for
the X-chromosome and can be easily confirmed by simulations. Thus, our
theoretical result here also resolves the long-standing analytical difficulty of
how to allow different baseline alleles between males and females in genetic
association studies. For the X-chromosome, modelling the GS interaction
effect has the added benefits of bypassing the X-inactivation uncertainty
challenge as discussed in Section 3.2.
We have shown that modelling the genetic dominant effect βD is bene-
ficial for both the autosomes and X-chromosome. The proposed model can
significantly increase test power when βD is large. When βD is close to 0,
the model is still robust and maintains comparable power with that of the
additive model. For the autosomes, we show analytically that even under
true additivity, compared with the classical 1 d.f. additive test, the maxi-
mum power loss of the 2 d.f. genotypic test is capped at 11.4%, regardless
of the sample, genetic effect and test sizes. Similarly, for the X-chromosome
analysis, with a 3 d.f. test that includes βA, βD and βGS interaction effects,
power loss is capped at 18.8% while the gain can be as high as 1 − α. Our
application results provide corroborating evidence. For the X-chromosome,
βD also captures potential skewness of X-inactivation as demonstrated in
Section 3.3.
In our autosome studies in Section 2.2, Figure 1 also demonstrates some
interesting patterns between power and allele frequencies. When f = 0.5
(middle plot), it is straightforward to see why, for the genotypic test (the
red solid curve), the minimum power occurs at βD = 0. Interestingly, power
of the additive test (the black dashed curve) in this case is constant across the
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range of βD. Let −a, d and a be the true effect sizes of the three genotypes,
rr, rR and RR, respectively. The additive effect captured by the additive
component is
a∗ = wrr(d− (−a)) + wRR(a− d) = a+ (wrr − wRR) · d,
where the weighting factors, wrr and wRR, are proportional to the corre-
sponding genotype frequencies, (1−f)2 and f2, respectively. When f = 0.5,
wrr = wRR and a
∗ ≡ a which explains why power of the additive test in this
plot is constant across the rage of dominant effects. Similarly, when f = 0.2
(left plot), wrr > wRR and a
∗ increases as βD increases from -0.6 to 0.6,
resulting in increased power of the additive test. Power of the genotypic test
also depends on the absolute size of βD, which leads to the non-monotone
pattern shown in the plot. Results of f = 0.8 mirror those of f = 0.2, as
expected.
When the true genetic model is unknown, one alternative direction is to
consider all possible models and use the ‘best’ or weighted average. But,
such an approach is difficult to implement in practice; see Bagos (2013) for
a review. For example, selection bias inherent in choosing the most fitted
model must be corrected for, often through computationally intensive sim-
ulation studies, and power of this bias-corrected inferential procedure is not
clear. On the other hand, ways to obtain a weighted average of the test
statistics or p-values across all models can be quite ad hoc, and the optimal
weighting factors are difficult to derive.
The proposed full model for analyzing an X-chromosome SNP, g(E(Y )) =
β0+βSS+βAGA+βDGD+βGSGS, is robust to various model uncertainties,
analytically. However, it is not capable of differentiating between the scenar-
ios. Using the available genetic association data, Ma et al. (2015) proposed
a variance-based test for detecting X-inactivation by comparing phenotypic
variance of the rR group with that of the rr and RR groups in females, but
this method is limited to a continuous trait (Soave & Sun, 2017; Deng et al.,
2018). Wang et al. (2014) explicitly introduced a parameter to represent the
amount of skewness of X-inactivation. Our work here, however, shows that
the interpretation of their parameter is confounded with potential dominant
genetic effect. How to incorporate additional ‘omic’ data (Carrel & Willard,
2005) to tease apart different biological phenomenons is an interesting prob-
lem that deserves further investigation.
SUPPLEMENTARY MATERIAL
(http://www.e-publications.org/ims/support/dowload/imsart-ims.zip). The
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online supplementary materials contain proof of Theorem 1 (Appendix A),
non-centrality parameter computation for correctly specified genetic mod-
els (Appendix B) and for misspecified genetic models (Appendix C), and
additional figures (Appendix D).
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Appendix A: Proof of Theorem 1
In Appendix A, we prove Theorem 1 stated in Section 3.1.
Case A: Linear Regression
We start from the special case of linear model. For notation simplicity we first rewrite the
null hypotheses in matrix form: H0 : Lβ1 = 0 under M1 and H0 : Lβ2 = 0 under M2,
where L = (0(q,p−q), Iq) is a combination of q× (p− q) zero matrix and identity matrix with
dimension q.
In the case of the linear model, it is well known (Vandaele, 1981) that the Wald, Score
and LRT test statistics for H0 are all functions of the F-statistic. So it is sufficient to show
that the F-statistic is the same forM1 andM2. Specifically, the F-statistic underMj for
j = 1, 2 is
Fj =
Qj/q
(Y −Xj(X ′jXj)−1X ′jY )′(Y −Xj(X ′jXj)−1X ′jY )/(n− p)
∼ F (q, n− p),
where
Qj = Y
′Xj(X ′jXj)
−1L′(L(X ′jXj)
−1L′)−1L(X ′jXj)
−1X ′jY.
If Xj denotes the covariate matrix used in model Mj, then consider a partition of its
columns into Xj = (Xj1Xj2) such that the effect of Xjk on the response is βjk for j, k = 1, 2.
We partition (X ′jXj)
−1 into 4 blocks: (X ′jXj)
−1 =
 X11j X12j
X21j X
22
j
. Then L′(L(X ′1X1)−1L′)−1L
is simplified to
 0 0
0 (X221 )
−1
, which implies
Q1 = Y
′X1(X ′1X1)
−1
 0 0
0 (X221 )
−1
 (X ′1X1)−1X ′1Y
2
Next, X2 = X1T implies L
′(L(X ′2X2)
−1L′)−1L =
 0 0
0 T ′2(X
22
1 )
−1T2
 , and
(T ′)−1L′(L(X ′2X2)
−1L′)−1LT−1
=
 (T ′1)−1 0
(T ′2)
−1T ′12(T
′
1)
−1 (T ′2)
−1
 0 0
0 T ′2(X
22
1 )
−1T2
 T−11 T−11 T12T−12
0 T−12

=
 0 0
0 (X221 )
−1
 .
Hence,
Q2 = Y
′X1TT−1(X ′1X1)
−1(T ′)−1L′(L(X ′2X2)
−1L′)−1LT−1(X ′1X1)
−1(T ′)−1T ′X ′1Y
= Y ′X1(X ′1X1)
−1
 0 0
0 (X221 )
−1
 (X ′1X1)−1X ′1Y = Q1.
On the other hand, X2(X
′
2X2)
−1X2 = X1TT−1(X ′1X1)
−1(T ′)−1T ′X ′1 = X1(X
′
1X1)
−1X1.
Therefore, F1 = F2. Finally, the Wald, Score and LRT statistics are
Wald =
nqF
n− p ;Score =
nqF
qF + n+ p
;LRT = n log(1 +
qF
n− p).
Since F does not change, they are all invariant to the linear transformation T betweenM1
and M2.
Case B: Generalized Linear Regression.
In generalized linear model, the three test statistics usually do not have closed forms, and
they are calculated from βˆj and β˜j , the unconstrained and constrained MLE of βj , which
are usually estimated by numerical methods. Throughout the proof, we use ·ˆ and ·˜ to
denote unconstrained and, respectively, constrained (under H0) estimators. For sample
size n, we use the standard notations of GLM, where
µ = (µ1, ..., µn) = g
−1(Xβ),
3
V (µi) = V ar(Yi)/φ, V (µ) = diag[V (µ1), ..., V (µn)],
w(µi) = 1/(V (µi)[g
′(µi)]2),W (µ) = diag[w(µ1), ..., w(µn)],
z(µi) = g
−1(µi) + g′(µi)(Yi − µi), z(µ) = [z(µ1), ..., z(µn)].
The proof under generalized linear model relies on the following two assumptions:
1. βˆj and β˜j are estimated by iterative reweighted least squares method, and they have
an initial value of 0, i.e., βˆj
(0)
= β˜j
(0)
= 0.
2. If the dispersion parameter φ is unknown, it is estimated using φˆ = h(µˆ) and φ˜ = h(µ˜)
for some function h.
These two assumptions are commonly satisfied in GLM framework. For assumption 1,
there is no prior information that the effect size is positive or negative, so it is reasonable
to choose an initial value of zero. For assumption 2, there exist several possible estimators
of φ in practice, but the most commonly used estimators are all functions of µ, e.g., φˆ =
1
n
∑n
i=1
(Yi−µˆi)2
V (µˆi)
.
We first show that X1βˆ1 = X2βˆ2, and X1β˜1 = X2β˜2. Under assumption 1, X1βˆ1
(0)
=
X2βˆ2
(0)
. If we further assume X1βˆ1
(k)
= X2βˆ2
(k)
, then it yields µˆ1
(k) = µˆ2
(k), V (µˆ1
(k)) =
V (µˆ2
(k)), W (µˆ1
(k)) = W (µˆ2
(k)) and z(µˆ1
(k)) = z(µˆ2
(k)). At (k + 1)th iteration,
X2βˆ2
(k+1)
= X2[X
′
2W (µˆ2
(k))X2]
−1X ′2W (µˆ2
(k))z(µˆ2
(k))
= X1TT
−1[X ′1W (µˆ1
(k))X1]
−1(T ′)−1T ′X ′1W (µˆ1
(k))z(µˆ1
(k))
= X1βˆ1
(k+1)
.
Therefore, mathematical induction and a simple limiting argument lead to X1βˆ1 = X2βˆ2.
Under the null hypothesis, we use the same argument on the submatrix X11, X21 and
4
transformation matrix T1 to show X11β˜11 = X21β˜21, which leads to X1β˜1 = X2β˜2. It
immediately follows that βˆ1 = T βˆ2, β˜1 = T β˜2, µˆ1 = µˆ2 and µ˜1 = µ˜2.
Depending on the type of GLM, the dispersion parameter is either known (e.g., φ = 1
in logistic model) or unknown (e.g., φ = σ2 in linear model). However, the estimators of β
remain the same regardless of whether the dispersion parameter φ is known or unknown.
When φ is known, it is trivial that φ remains equal under M1 and M2. When φ is un-
known, we replace φ by its estimator. Because µˆ1 = µˆ2 and µ˜1 = µ˜2, under assumption
2, φˆ and φ˜ also remain unchanged underM1 andM2. We discuss below each of the three
tests, Wald, Score and LR in detail.
(i) The Wald statistic is
Waldj =
n
φˆ
{βˆj ′L′[L(X ′jW (µˆj)Xj)−1L′]−1Lβˆj}.
Because βˆ2 = T
−1βˆ1 and W (µˆ2) = W (µˆ1),
Wald2 =
n
φˆ
(βˆ1
′
(T−1)′L′[LT−1(X ′1W (µˆ1)X1)
−1(T ′)−1L′]−1LT−1βˆ1).
We consider a partition (X ′1W (µˆ1)X1)
−1 and follow the approach used for Case A to show
(T−1)′L′[LT−1(X ′1W (µˆ1)X1)
−1(T ′)−1L′]−1LT−1 = L′[L(X ′1W (µˆ1)X1)
−1L′]−1L.
Therefore, Wald1 = Wald2.
(ii) The Score statistic is defined by Cordeiro et al. (1993) as
Scorej =
1
φ˜
(Y−µ˜j)′V (µ˜j)−1/2W (µ˜j)1/2Xj2(R˜j ′W (µ˜)R˜j)−1X ′j2W (µ˜j)1/2V (µ˜j)−1/2(Y−µ˜j),
5
where
Rj = Xj2 −Xj1(X ′j1W (µj)Xj1)−1X ′j1W (µj)Xj2.
First, we note that
(X21, X22) = (X11, X12)
 T1 T12
0 T2
 = (X11T1, X11T12 +X12T2)
and W (µ˜2) = W (µ˜1). Thus
R˜2 = X11T12 +X12T2 −X11T1(T ′1X ′11W (µ˜2)X11T1)−1T ′1X ′11W (µ˜2)(X11T12 +X12T2)
= X12T2 −X11(X ′11W (µ˜1)X11)−1X ′11W (µ˜2)X12T2) = R˜1T2
From the estimating equations for the constrained MLE of β,
(Y − µ˜j)′V (µ˜j)−1/2W (µ˜j)1/2Xj1 = 0.
Hence,
(Y − µ˜2)′V (µ˜2)−1/2W (µ˜2)1/2X22 = (Y − µ˜1)′V (µ˜1)−1/2W (µ˜1)1/2(X11T12 +X12T2)
= (Y − µ˜1)′V (µ˜1)−1/2W (µ˜1)1/2X12T2.
Therefore,
Score2 =
1
φ˜
(Y − µ˜1)′V (µ˜1)−1/2W (µ˜1)1/2X12T2(T ′2R˜1
′
W (µ˜1)R˜1T2)
−1·
T ′2X
′
12W (µ˜1)
1/2V (µ˜1)
−1/2(Y − µ˜1) = Score1.
(iii) The LRT statistic is
LRTj = 2
n∑
i=1
[log f(Yi, βˆj)− log f(Yi, β˜j)].
6
The density function of Yi belongs to the exponential family
f(Yi,βj) = exp
[
YiX
′
ijβj − b(X ′ijβj)
φ
+ c(Yi, φ)
]
,
so X1βˆ1 = X2βˆ2 and X1β˜1 = X2β˜2 imply f(Yi, βˆ1) = f(Yi, βˆ2) and f(Yi, β˜1) = f(Yi, β˜2).
Therefore, LRT1 = LRT2.
Appendix B: Non-centrality Parameter Computation
for Correctly Specified Genetic Models
We provide the details for computing non-centrality parameters for the tests under different
genetic models. When the model is correctly specified, ncpmay be computed using equation
ncp = β′2[H22(β1, 0)−H21(β1, 0)H−111 (β1, 0)H12(β1, 0)]β2. (1)
as described in Section 2.2.
Equation (1) above computes exact ncp as a function of design matrix X. In order to
disentangle (1) from the sample-specific observed genotypes, we consider the asymptotic
behaviour of ncp as n → ∞. In order to avoid the uninteresting case in which ncp → ∞
when n grows, we assume β = c/
√
n (see also Cox and Hinkley, 1974; Begg and Lagakos,
1992, 1993; Neuhaus, 1998) for a fixed vector c, so that β → 0 and ncp converges to a
finite number as n→∞.
In the case of a linear model with covariate matrix X, H = X
′X
σ2
regardless of β. Let P
be the limit of X
′X
n
:
X ′X
n
p→ P.
7
Corresponding to the split β = (β1, β2), P is partitioned as P =
 P11 P12
P21 P22
. The
asymptotic value of ncp is then computed following equation (1):
ncp(linear)
p→ 1
σ2
c′2[P22 − P21(P11)−1P12]c2,
where c2 = β2
√
n.
In the logistic model, H(β) = X ′W (β)X, where W (β) is the n × n diagonal matrix
with the ith diagonal element equal to µi(β)(1−µi(β)), and µ(β) = exp(Xβ)1+exp(Xβ) . As n→∞,
β → 0 so that µi(β)(1− µi(β)) p→ 14 , which implies
X ′W (β)X
n
p→ P
4
.
Hence, the asymptotic non-centrality parameter under logistic model is
ncp(logistic)
p→ 1
4
c′2[P22 − P21(P11)−1P12]c2.
Note that if σ2 = 4, the linear and logistic model have equal asymptotic ncp as long as X
and β are the same. Under this scenario, in both models
ncp
p→ 1
σ2
c′2[P22 − P21(P11)−1P12]c2. (2)
This observation allows a convenient derivation of ncp in logistic models by plugging σ2 = 4
in the ncp formula for linear models.
Remark 1: Assume that the generative model is genotypic (for autosome SNPs) or
model M4 in Table 3 (for X-chromosome SNPs). If the additive model or one of the models
M1,M2,M3 are used for estimation, then the above derivation of ncp is not valid since the
estimators for β may be biased due to model misspecification.
8
However, when the true model is additive or one of models M1,M2,M3, the derivation
for ncp remains valid when using either the genotypic model or M4 for estimation, as the
MLE estimators of β remain unbiased. Therefore, ncp under the genotypic or M4 model
may be computed by equation (1) or (2) regardless of the true model.
Remark 2: Under genotypic model, β2 = (βA, βD), and
P =

1 E(GA) E(GD)
E(GA) E(G
2
A) E(GA ·GD)
E(GD) E(GA ·GD) E(G2D)
 .
Under M4, β2 = (βA, βD, βGS) and
P =

1 E(S) E(GA) E(GD) E(GS)
E(S) E(S2) E(S ·GA) E(S ·GD) E(S ·GS)
E(GA) E(S ·GA) E(G2A) E(GA ·GD) E(GA ·GS)
E(GD) E(S ·GD) E(GA ·GD) E(G2D) E(GD ·GS)
E(GS) E(S ·GS) E(GA ·GS) E(GD ·GS) E(GS2)

.
Assuming equal population frequency of females and males, E(S) = 0.5. Other expected
values are computed from the ‘risk’ allele frequencies (ffemale and fmale). Although different
codings of GA and GI may lead to different expected values, the test statistics are common
(following Theorem 1) thus implying that the ncp form is asymptotically coding-invariant.
Appendix C: Non-centrality Parameter Computation
for Misspecified Genetic models
Under model misspecification, the derivations in Appendix B may not be applicable. In
this section, we provide an alternative approach for deriving ncp by reparametrizing the
9
covariates without changing the test statistics. The approach is illustrated with a series of
examples.
Example 1: Additive model is misspecified when dominant effect is present
The following four steps are used to compute the correct ncp:
S1 We reparametrize GA and GD as G
∗
A and G
∗
D such that the test statistic for the
null H0 : β
∗
A = β
∗
D = 0 is the same as that for H0 : βA = βD = 0 under the
original genotypic model. From Theorem 1 it is sufficient that (1, G∗A, G
∗
D) is a linear
transformation of (1, GA, GD).
S2 We next test β∗A = 0 under the reparametrized genotypic model Y ∼ G∗A + G∗D.
Because the reparametrized genotypic model is correctly specified, the asymptotic
ncp for this test can be computed following equation (2).
S3 We show that when corr(G∗A, G
∗
D) = 0, the re-parametrized additive model: Y ∼ G∗A
and genotypic model: Y ∼ G∗A +G∗D have asymptotic equal ncp for testing β∗A = 0.
S4 We require (1, G∗A) to be a linear transformation of (1, GA). Then by Theorem 1,
testing β∗A = 0 under Y ∼ G∗A has the same test statistic as testing βA = 0 under
Y ∼ GA. Therefore, the correct ncp for testing βA = 0 under original additive model
Y ∼ GA is asymptotically equal to the ncp computed in step 1.
S1: We define G∗A = (−1, 0, 1) and G∗D = (−2f 2, 2f(1 − f),−2(1 − f)2) for genotype
rr, rR and RR. Direct verification shows corr(G∗A, G
∗
D) = 0. Also note that (1, G
∗
A, G
∗
D)
and (1, G∗A) are linear transformations of (1, GA, GD) and (1, GA). Under the new codings,
β is also re-parametrized so that β∗A = βA + βD(1− 2f) and β∗D = βD.
Remark 3 Note that the new codings are hard to interpret and we do not recommend using
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them for effect estimates. Their sole purpose is to facilitate the asymptotic calculation of
ncp.
S2 See previous section.
S3 For logistic models, Begg and Lagakos (1992) showed the equivalence and we apply
their conclusion directly. Here we provide the proof for the linear model.
Because the re-parametrized genotypic model Y ∼ G∗A + G∗D is correctly specified, the
asymptotic ncp for testing β∗A = 0 can be computed following equation (2). With the new
coding of G∗A and G
∗
D, we have
P ∗ =

1 −1 + 2f 0
−1 + 2f 1− 2f + 2f 2 0
0 0 4f 2(1− f)2
 .
For testing β∗A = 0, β
∗ is partitioned as β∗1 = (β
∗
0 , β
∗
G) and β
∗
2 = β
∗
A. P
∗ is partitioned
accordingly so that
P ∗11 =
 1 0
0 4f 2(1− f)2
 , P ∗21 = P ∗12′ = ( −1 + 2f 0 ) , P ∗22 = 1− 2f + 2f 2.
Therefore,
ncp
p→ 1
σ2
c∗2
′[P ∗22 − P ∗21(P ∗11)−1P ∗12]c∗2 = 2f(1− f)
nβ∗A
2
σ2
.
To compute the ncp from the re-parametrized additive model Y ∼ G∗A, the model is
misspecified so that we need to work on the ncp directly. The chi-squared statistic is
W =
βˆ∗A
′
L′(L(X∗A
′X∗A)
−1L′)−1Lβˆ∗A
σ2
,
where βˆ∗A = (βˆ
∗
0 , βˆ
∗
A)
′ is the least square estimator of (β0, βA)′, X∗A = (1, G
∗
A) and L =[
0 1
]
.
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Because the genotypic model is the true model, Y ∼ N(X∗β∗, σ2In), where X∗ =
(1, G∗A, G
∗
D) and β
∗ = (β∗0 , β
∗
A, β
∗
D)
′. It implies that
βˆ∗A = (X
∗
A
′X∗A)
−1X∗A
′Y ∼ N((X∗A′X∗A)−1X∗A′X∗β∗, (X∗A′X∗A)−1σ2),
and thus
Lβˆ∗A ∼ N(L(X∗A′X∗A)−1X∗A′X∗β∗, L(X∗A′X∗A)−1L′σ2).
Therefore, W ∼ χ2(1,ncpA) where
ncpA =
1
σ2
β∗′X∗′X∗A(X
∗
A
′X∗A)
−1L′(L(X∗A
′X∗A)
−1L′)−1L(X∗A
′X∗A)
−1X∗A
′X∗β∗.
Next, X∗β∗ = X∗A(β
∗
0 , β
∗
A)
′+ β∗DG
∗
D, so we may decompose ncpA into three parts such that
ncpA = a1 + a2 + a3, where
a1 =
1
σ2
(β∗0 , β
∗
A)L
′(L(X∗A
′X∗A)
−1L′)−1L(β∗0 , β
∗
A)
′,
a2 =
2
σ2
β∗DG
∗
D
′X∗A(X
∗
A
′X∗A)
−1L′(L(X∗A
′X∗A)
−1L′)−1L(β∗0 , β
∗
A)
′,
a3 =
1
σ2
β∗DG
∗
D
′X∗A(X
∗
A
′X∗A)
−1L′(L(X∗A
′X∗A)
−1L′)−1L(X∗A
′X∗A)
−1X∗A
′G∗Dβ
∗
D.
Because
1
n
G∗D
′X∗A
p→ (E[G∗D], E[G∗AG∗D]) = (0, 0)
and
β∗ =
c∗√
n
p→ 0,
we have a2
p→ 0 and a3 p→ 0. To compute a1,
1
n
X∗A
′X∗A =
1
n
 n ∑G∗A∑
G∗A
∑
G∗A
2
 p→
 1 −1 + 2f
−1 + 2f 1− 2f + 2f 2
 ,
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which implies
nL(X ′AXA)
−1L′
p→ 1
2f(1− f) .
Therefore,
ncpA
p→ a1 p→ 2f(1− f)nβ
∗
A
2
σ2
,
which completes the proof that the two asymptotic non-centrality parameters are equal.
Example 2: M1, M2 and M3 are misspecified models when M4 is the true
model.
As in the previous example, the reparametrized coding (1, S∗, G∗A, G
∗
D, GS
∗) must be a
linear transformation of (1, S,GA, GD, GS), and (1, S
∗) must also be a linear transformation
of (1, S).
The way to code GA and GS is not an issue because we can show the equivalency of
(1, S,GA, GD, GS) under each way of coding by applying Theorem 1, as summarized in
Figure S4. The requirements in S3 and S4 are discussed below for models M1 −M3.
M1 To compute ncp1 for testing βA = 0 under M1, we require
corr(G∗D, G
∗
A) = corr(GS
∗, G∗A) = 0,
and (1, S∗, G∗A) is linear transformation of (1, S,GA).
M2 To compute ncp2 for testing βA = βD = 0 under M2, we require
corr(GS∗, G∗A) = corr(GS
∗, G∗D) = 0,
and (1, S∗, G∗A, G
∗
D) is linear transformation of (1, S,GA, GD).
M3 To compute ncp3 for testing βA = βGS = 0 under M3, we require
corr(G∗D, G
∗
A) = corr(G
∗
D, GS
∗) = 0,
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and (1, S∗, G∗A, GS
∗) is linear transformation of (1, S,GA, GS).
We can show ncp1, ncp2 and ncp3 are asymptotically equal to the ncps for testing
β∗A = 0, β
∗
A = β
∗
D = 0 and β
∗
A = β
∗
GS = 0 under the correctly specified re-parametrized
model M4: Y ∼ S∗ + G∗A + G∗D + GS∗, which can be computed using equation (2). The
proof under logistic model is a direct application of Begg and Lagakos (1992)’s result. The
proof under linear models is omitted because it is similar to the Example 1 above but
much more lengthy.
The remaining question is to find the re-parametrized codings satisfying the above
conditions. We provide such codings in Table S1.
Table S1: Re-parametrized codings of additive, dominant, interaction and sex effect
Female Male
Coding rr rR RR r R
G∗A -1 0 1 -1 1
G∗D −2f 2female 2ffemale(1− ffemale) −2(1− ffemale)2 0 0
GS∗ −ffemale 12 − ffemale 1− ffemale
ffemale(1−ffemale)
2(1−fmale) −
ffemale(1−ffemale)
2fmale
S∗ -1 -1 -1 1 1
Remark 4: If the missing covariates in the misspecified model are uncorrelated to the
covariate being tested, for finite sample it is well-known that the estimator from misspecified
model should be unbiased but less efficient. However, we find the ncps are asymptotically
equal under the true model and under the misspecified model using re-parametrized codings.
This suggests that the misspecified model is asymptotically as efficient as the true model,
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in contradiction with the finite sample result. This tension appears because we assume
that the nuisance parameter β1 also converges to 0. For instance, Begg and Lagakos (1992)
considered the situation in which only β2 converges to 0, and their derivations showed that
the asymptotic relative efficiency of the misspecified model and true model is less than 1,
in agreement with small sample results.
Remark 5: The ncp computation in our paper focuses on linear and logistic regressions,
but it is possible to extend to other generalized linear models (GLMs). Although there
is no result to be directly used for GLMs in general, Neuhaus (1998) extended Begg and
Lagakos (1992)’s relative efficiency calculation to GLMs. It can be used to extend the
asymptotic equivalence of ncp to other types of GLM.
Appendix D: Additional Figures
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Figure S1: Heat plots of power and power loss for 1, 2 and 3 degree of freedom
chi-squared distributions. Upper panels: Power of W1 ∼ χ2(1,ncp), W2 ∼ χ2(2,ncp) and
W3 ∼ χ2(3,ncp) as a function of − log10 α (type I error) and non-centrality parameter. Lower
panels: Power loss of W2 vs W1, W3 vs W1 and W3 vs W2 as a function of − log10 α
and non-centrality parameter assuming equal non-centrality parameter within each pair.
Black dots correspond to maximum power loss: α = 0.0025 and ncp = 10.6 for left panel,
α = 0.0008 and ncp = 13.4 for middle panel and α = 9.12 × 10−5 and ncp = 19 for right
panel.
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Figure S2: Test power comparison between W1 ∼ χ2(1,ncp1) and W2 ∼ χ2(2,ncp2), when
ncp1 = 5, 10 or 15 and ∆12 = ncp2 − ncp1 varying from 0 to 10. Black dash curves are
power of W1; red solid curves are power of W2. Type I error α = 0.0025.
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Figure S3: Non-centrality parameter comparison between the additive and geno-
typic tests for association analyses of autosome SNPs across a range of dominant
effects, including no dominant effect. The additive effect is fixed at βA = 0.3, while
the dominant effect βD ranges from −0.6 to 0.6. The allele frequency f = 0.2, 0.5, and
0.8 for the three plots, respectively, from left to right, the sample size n = 1, 000, and the
size of the test α = 0.0025. The black dashed curves are power of testing βA = 0 using
the additive model, and the red solid curves are power of testing βA = βD = 0 using the
genotypic model.
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(a)
g(E(Y )) = β0 + βAGA
H0 : βA = 0
(b)
g(E(Y )) = β0 + βAGA + βDGD
H0 : βA = βD = 0
(a)
g(E(Y )) = β0 + βSS + βAGA
H0 : βA = 0
(b)
g(E(Y )) = β0 + βSS + βAGA + βDGD
H0 : βA = βD = 0
(a)
g(E(Y )) = β0 + βSS + βAGA + βGSGS
H0 : βA = βGS = 0
(b)
g(E(Y )) = β0 + βSS + βAGA + βDGD + βGSGS
H0 : βA = βD = βGS = 0
GA,R,I GA,r,I
GA,R,N GA,r,N
S,GA,R,I S,GA,r,I
S,GA,R,N S,GA,r,N
S,GA,R,I , GSR S,GA,r,I , GSr
S,GA,R,N , GSR S,GA,r,N , GSr
Z
Z
Z


Figure S4: Equivalency between different regression models for association stud-
ies of the X-chromosome. The subscript R or r represents the designated allele of which
we count the number of copies present in a genotype (‘risk’ allele), and I or N denotes X-
chromosome inactivated or not inactivated. Two group of codings connected by a straight
line if there is an invertible linear transformation between the design matrices as specified
in Theorem 1, and the resulting test statistics for testing the specified H0 will be identical
to each other. Part (a) corresponds to models and tests without the dominant covariate,
GD, and part (b) corresponds to models and tests with GD included. Inclusion of GD has
no effect to the linear relationships established in part (a), because there is only one GD
coding as defined in Table 2.
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A. ffemale = 0.2, fmale = 0.5
B. ffemale = 0.2, fmale = 0.8
20
C. ffemale = 0.5, fmale = 0.2
D. ffemale = 0.5, fmale = 0.8
21
E. ffemale = 0.8, fmale = 0.2
F. ffemale = 0.8, fmale = 0.5
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G. ffemale = 0.8, fmale = 0.8
Figure S5: Power comparisons for analyzing X-chromosome SNPs. Additional
values of f which are not presented in Figure 2 are specified through part A to G. Black
dash curves for testing βA = 0 based on model M1, green dot-dash curves for testing
βA = βD = 0 based on model M2, orange dotted curves for testing βA = βGS = 0 based
on model M3, and red solid curves for testing βA = βD = βGS = 0 based on the proposed
model M4. Upper panels examine power as a function of dominant effect (or skewness of
XCI). Lower panels examine power as a function of gene-sex interaction effect (or XCI
status).
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Figure S6: Results of re-analyses of the 60 autosomal, presumably associated,
SNPs selected by Wittke-Thompson et al. (2005) from 41 association studies.
X-axis is the p-value, on the −log10 scale, obtained from the standard 1 d.f. additive test
and the Y-axis is the recommended 2 d.f. genotypic test.
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Figure S7: QQ-plots of the 556,445 autosome SNPs from cystic fibrosis study in
Section 4.3. Left panel: p-values of the additive test on −log10 scale. Right panel:
p-values of the genotypic test on −log10 scale. The QQ-plots imply that p-values are
approximately Uniform(0,1) distributed for either test.
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Figure S8: p-values of the additive test vs. genotypic test on −log10 scale of
the 556,445 autosome SNPs from cystic fibrosis study in Section 4.3. Due to
the capped maximal power loss computed in Section 2.1, p-values under genotypic model
is possible to be much smaller than additive model, but not possible to be much greater
than additive model, which clearly demonstrates the benefit of genotypic model. It needs
to be noted that the capped power loss does not contradict to the fact that the overall p-
values under both additive and genotypic model have the same Uniform(0,1) distribution,
as shown in Figure S7.
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